Delivery Order SPE2DB22D2005-SPE2DB25FJKZ8

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,319.57 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for M-M-R II vaccine vials. The order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through November...
This is a $19,119.99 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of M-M-R II vaccine vials. The contract has a period of performance through July 18, 2024 and does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) by the DLA and other agencies to provide a wide range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, rubella) vaccine vials. The delivery order has a firm fixed price of $1,279.24 and a ceiling value of $1,279.24, with a completion date of July 29, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a $2,543.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II VACCINE VIALS. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. There is no set-aside designation for this...
This is a $26,643.76 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of July 19, 2024 and does not utilize a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract has a firm fixed price of $5,878.20 and a completion date of April 8, 2025. The award is not set aside and was made under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00, which provides comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract has a firm fixed-price of $1,537.14 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a $1,049.66 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of M-M-R II vaccine vials. The award does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of prescription drugs, medical supplies, and vaccines to support military treatment facilities and other federal healthcare programs. This delivery order is part of a...
This is a $6,949.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II vaccine vials and has an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a $1,107.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of M-M-R II vaccine vials and has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJKZ8
    Delivery Order

This is a $1,107.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,567,880,630 vials of the M-M-R II (measles, mumps, rubella) vaccine. The delivery order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order does not have a set-aside designation, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through streamlined pharmaceutical and medical supply procurement.

Generated 7/11/25, 9:51 AM